Date Filed | Type | Description |
06/18/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
06/14/2018 |
SC 13G
| INTEGRATED CORE STRATEGIES LLC reports a 0% stake in GREAT PLAINS ENERGY INCORPORATED |
06/06/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/04/2018 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
06/04/2018 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t... |
05/25/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
05/02/2018 |
8-K
| Quarterly results |
05/02/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
05/02/2018 |
BW
| Great Plains Energy Reports Solid First Quarter 2018 Results |
04/25/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
04/17/2018 |
BW
| Great Plains Energy Announces Schedule for First Quarter 2018 Earnings |
04/06/2018 |
SC 13G/A
| BlackRock Inc. reports a 10.6% stake in GREAT PLAINS ENERGY INCORPORATED |
03/12/2018 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
03/01/2018 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"SIGNATURES",
"Underwriting Agreement among KCP&L, J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein",
"Supplemental Indenture No. 7 between KCP&L and The Bank of New York Mellon Trust Company, N.A., as trustee",
"Opinion of Hunton & Williams LLP" |
|
02/21/2018 |
8-K
| Quarterly results |
02/21/2018 |
BW
| Great Plains Energy Reports Full-Year 2017 Results |
02/21/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
02/20/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2018 |
GN
| Analysis: Positioning to Benefit within Great Plains Energy, Flowers Foods, Hasbro, BIOHAVEN PHARM, Vonage, and NOW — Research Highlights Growth, Revenue, and Consolidated Results |
02/06/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/26/2018 |
BW
| Great Plains Energy Announces Schedule for Fourth Quarter and Year-End 2017 Earnings |
01/23/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/12/2018 |
8-K
| Other Events |
01/10/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
11/21/2017 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
11/17/2017 |
GN
| New Research: Key Drivers of Growth for Great Plains Energy, Flowers Foods, Hasbro, Acadia Healthcare, DXC Technology, and Alnylam Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production |
|